Polymorphism of doxazosin mesylate

Archives of Pharmacal Research

Volumn 28, Issue 6, 2005, Pages 730-735

  Sohn, Young Taek ^a   Lee, Yoon Hee ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Doxazosin mesylate; DSC; Polymorphism; PXRD; TG; Transformation

Indexed keywords

DOXAZOSIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; THERMOGRAVIMETRY; X RAY CRYSTALLOGRAPHY;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DOXAZOSIN; MOLECULAR STRUCTURE; THERMOGRAVIMETRY;

EID: 24944444377     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02969365     Document Type: Article

References (12)

1. Borka, L., Reviews on crystal polymorphism of substances in the European Pharmacopoeia. Pharm. Acta Helv., 66, 16-22 (1991).
2. Giron, D., Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim. Acta, 248, 1-59 (1995).
3. Grcman, M., Vrecer, F., and Meden, A., Some physico-chemical properties of Doxazosin mesylate polymorphic forms and its amorphous state. J. Therm. Anal. Cal., 68, 373-387 (2002).
4. Giridhar, T., Reddy, R. B.. and Ramesh, C., Methods for the preparation of polymorphs of doxazosin mesylate. US 6,399,775 B1 (2002).
5. Gruenenberg, A., Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit, 26, 224-231 (1997).
6. Haleblian, J. and McCrowne, W., Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58, 911-929 (1969).
7. Haleblian, J., Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64, 1269-1288 (1975).
8. Kuhnert-Brandstaetter, M., Polymorphie von Arzneistoffen und ihre Bedeutung in der pharmazeutischen Technologie. Informationsdienst A.P.V., 19, 73-90 (1973).
9. Sohn, Y. T., Effect of polymorphism on bioavailability of amoxicillin. Yakhak Hoeji, 39, 438-443 (1995).
10. Sohn, Y. T. and Kim, S. Y., Effect of crystal form on in vivo topical anti-inflammatory activity of corticosteroids. Arch. Pharm. Res., 25, 556-559 (2002).
11. Sun, C. and Grant, D. J. W., Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm. Res., 18, 274-280 (2001).
12. Yoshinari, T., Forbes, R. T., York, P., and Kawashima, Y., The improved compaction properties of mannitol after a moisture-induced polymorphic transition. Int. J. Pharm., 258, 121-131 (2003).